| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.007 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.092 | 0.007 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.008 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.008 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.095 | 0.008 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.008 |
| mRNA | Mdivi-1 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.009 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.009 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |